AFP and liver cancer: The use of AFP in addition to US significantly improves the sensitivity of screening and is recommended as the most widely adopted strategy by Chinese guidelines for liver cancer screening but at the cost of reduced specificity [14]; this suggests that many early-stage cases might be missed at diagnosis due to false-negative results, with significant treatment costs generated as a result of disease progression [15].